Company intelligence / Profile preview

Occyo

Ownership: Private
Development stage: Other

Overview

Occyo has developed and commercialized an advanced ocular surface imaging device, CORNEA DOME LENs, enabling standardized image capture for semi-automated diagnosis and monitoring of eye diseases. The technology is used by ophthalmologists and telemedicine providers to improve diagnostic accuracy and patient outcomes in eye care. No clinical trial results are reported as this is a medical device rather than a therapeutic.

Therapeutic areas: Ophthalmology
Modalities: Device
Industry: Medical Imaging

Beyond the preview

Go deeper on Occyo.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Occyo.

Explore the full profile